US Stock MarketDetailed Quotes

KTRA Kintara Therapeutics

Watchlist
  • 0.1802
  • +0.0063+3.62%
Close Sep 9 16:00 ET
  • 0.1841
  • +0.0039+2.16%
Post 19:49 ET
9.98MMarket Cap-77P/E (TTM)

Kintara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-36.86%2.09M
-70.88%1.02M
-36.25%2.96M
-34.77%14.8M
-38.64%3.35M
-38.37%3.3M
-40.64%3.5M
-22.19%4.65M
5.15%22.68M
-18.50%5.46M
Selling and administrative expenses
15.11%1.49M
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
-23.04%7.51M
-45.46%1.45M
-General and administrative expense
15.11%1.49M
-36.94%908K
-25.22%1.1M
-26.95%5.49M
-12.45%1.27M
-31.16%1.3M
-27.75%1.44M
-32.28%1.48M
-23.04%7.51M
-45.46%1.45M
Research and development costs
-70.47%592K
-94.61%111K
-41.37%1.86M
-38.63%9.31M
-48.15%2.08M
-42.29%2.01M
-47.23%2.06M
-16.40%3.17M
28.42%15.17M
-0.67%4M
Operating profit
36.86%-2.09M
70.88%-1.02M
36.25%-2.96M
34.77%-14.8M
38.64%-3.35M
38.37%-3.3M
40.64%-3.5M
22.19%-4.65M
-5.15%-22.68M
18.50%-5.46M
Net non-operating interest income expense
89.74%74K
-95.56%2K
-94.87%2K
878.57%137K
27.27%14K
3,800.00%39K
4,400.00%45K
3,800.00%39K
111.67%14K
142.31%11K
Total other finance cost
-89.74%-74K
95.56%-2K
94.87%-2K
-878.57%-137K
-27.27%-14K
-3,800.00%-39K
-4,400.00%-45K
-3,800.00%-39K
-111.67%-14K
-142.31%-11K
Other net income (expense)
-6K
-118.18%-2K
42.86%10K
0
-200.00%-1K
175.00%11K
100.04%7K
111.11%1K
Gain on sale of security
----
---6K
-118.18%-2K
42.86%10K
--0
-200.00%-1K
----
175.00%11K
158.33%7K
111.11%1K
Income before tax
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
Income tax
Net income
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
Net income continuous Operations
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
Minority interest income
Net income attributable to the parent company
38.39%-2.01M
70.38%-1.02M
35.55%-2.96M
35.36%-14.65M
38.76%-3.34M
39.06%-3.26M
41.39%-3.45M
22.96%-4.6M
40.83%-22.66M
19.10%-5.45M
Preferred stock dividends
0.00%2K
0.00%2K
-51.92%175K
-85.02%370K
0.00%2K
0.00%2K
0.00%2K
-85.23%364K
-22.96%2.47M
-50.00%2K
Other preferred stock dividends
Net income attributable to common stockholders
38.36%-2.01M
70.34%-1.03M
36.75%-3.14M
40.24%-15.02M
38.75%-3.34M
39.04%-3.27M
41.37%-3.46M
41.16%-4.96M
39.45%-25.13M
19.12%-5.45M
Basic earnings per share
97.42%-0.05
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
67.75%-25.8
47.54%-3.41
Diluted earnings per share
97.42%-0.05
88.57%-0.24
46.02%-1.83
64.07%-9.27
42.82%-1.95
64.40%-1.94
65.40%-2.1
72.88%-3.39
67.75%-25.8
47.54%-3.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022(FY)Jun 30, 2022(Q4)Jun 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -36.86%2.09M-70.88%1.02M-36.25%2.96M-34.77%14.8M-38.64%3.35M-38.37%3.3M-40.64%3.5M-22.19%4.65M5.15%22.68M-18.50%5.46M
Selling and administrative expenses 15.11%1.49M-36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M-23.04%7.51M-45.46%1.45M
-General and administrative expense 15.11%1.49M-36.94%908K-25.22%1.1M-26.95%5.49M-12.45%1.27M-31.16%1.3M-27.75%1.44M-32.28%1.48M-23.04%7.51M-45.46%1.45M
Research and development costs -70.47%592K-94.61%111K-41.37%1.86M-38.63%9.31M-48.15%2.08M-42.29%2.01M-47.23%2.06M-16.40%3.17M28.42%15.17M-0.67%4M
Operating profit 36.86%-2.09M70.88%-1.02M36.25%-2.96M34.77%-14.8M38.64%-3.35M38.37%-3.3M40.64%-3.5M22.19%-4.65M-5.15%-22.68M18.50%-5.46M
Net non-operating interest income expense 89.74%74K-95.56%2K-94.87%2K878.57%137K27.27%14K3,800.00%39K4,400.00%45K3,800.00%39K111.67%14K142.31%11K
Total other finance cost -89.74%-74K95.56%-2K94.87%-2K-878.57%-137K-27.27%-14K-3,800.00%-39K-4,400.00%-45K-3,800.00%-39K-111.67%-14K-142.31%-11K
Other net income (expense) -6K-118.18%-2K42.86%10K0-200.00%-1K175.00%11K100.04%7K111.11%1K
Gain on sale of security -------6K-118.18%-2K42.86%10K--0-200.00%-1K----175.00%11K158.33%7K111.11%1K
Income before tax 38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M
Income tax
Net income 38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M
Net income continuous Operations 38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M
Minority interest income
Net income attributable to the parent company 38.39%-2.01M70.38%-1.02M35.55%-2.96M35.36%-14.65M38.76%-3.34M39.06%-3.26M41.39%-3.45M22.96%-4.6M40.83%-22.66M19.10%-5.45M
Preferred stock dividends 0.00%2K0.00%2K-51.92%175K-85.02%370K0.00%2K0.00%2K0.00%2K-85.23%364K-22.96%2.47M-50.00%2K
Other preferred stock dividends
Net income attributable to common stockholders 38.36%-2.01M70.34%-1.03M36.75%-3.14M40.24%-15.02M38.75%-3.34M39.04%-3.27M41.37%-3.46M41.16%-4.96M39.45%-25.13M19.12%-5.45M
Basic earnings per share 97.42%-0.0588.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.3967.75%-25.847.54%-3.41
Diluted earnings per share 97.42%-0.0588.57%-0.2446.02%-1.8364.07%-9.2742.82%-1.9564.40%-1.9465.40%-2.172.88%-3.3967.75%-25.847.54%-3.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg